Clinical trial experts cite trust and regulatory uncertainty as AI barriers
The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.
Themes
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma?
Consecutive approvals of Opdivo for Hodgkin’s lymphoma to boost sales growth
Calls for change as access to cell and gene therapies in the Netherlands falls short
Kidney disease risk higher after Covid infection than after influenza infection
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Biorce secures $52.5m in Series A to expand AI clinical trial tech
